[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Rhodia: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

October 2010 | 63 pages | ID: R2740FB94C7EN
Venture Planning Group

US$ 1,520.00 US$ 1,900.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global PDF: US$ 4,100.00

A strategies assessment of Rhodia, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 63 pages and 7 tables
I. EXECUTIVE SUMMARY

II. BUSINESS ORGANIZATION

III. SENIOR MANAGEMENT

IV. FACILITIES AND EMPLOYEES

V. TECHNOLOGICAL KNOW-HOW

VI. PRODUCT PORTFOLIO

VII. MARKETING TACTICS

VIII. SALES AND PROFIT GROWTH

IX. R&D EXPENDITURES AND MAJOR PROGRAMS

X. COLLABORATIVE ARRANGEMENTS

XI. STRATEGIC DIRECTION

LIST OF TABLES


Table 1: Rhodia Sales and Operating Profit Growth
Table 2: Rhodia Sales by Enterprise
Table 3: Rhodia Sales Growth by Enterprise
Table 4: Rhodia Operating Profit and Margins by Enterprise
Table 5: Rhodia Operating Profit Growth by Enterprise
Table 6: Rhodia Sales by Geographic Region and Country
Table 7: Rhodia Sales Growth by Geographic Region and Country


More Publications